October Pharma S.A.E (EGX:OCPH)
102.49
0.00 (0.00%)
At close: May 13, 2025
October Pharma S.A.E Revenue
In the year 2024, October Pharma S.A.E had annual revenue of 1.23B EGP with 21.39% growth. October Pharma S.A.E had revenue of 342.12M in the quarter ending December 31, 2024, with 11.34% growth.
Revenue
1.23B
Revenue Growth
+21.39%
P/S Ratio
1.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.23B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.23B | 216.38M | 21.39% |
Dec 31, 2023 | 1.01B | 284.28M | 39.08% |
Dec 31, 2022 | 727.37M | 72.33M | 11.04% |
Dec 31, 2021 | 655.04M | 111.64M | 20.54% |
Dec 31, 2020 | 543.40M | 20.28M | 3.88% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Commercial International Bank Egypt (CIB) S.A.E. | 114.75B |
El Sewedy Electric Company | 231.98B |
Talaat Moustafa Group Holding | 42.67B |
Eastern Company S.A.E | 30.98B |
Misr Fertilizer Production Company | 19.65B |
Abu Qir Fertilizers and Chemical Industries Co. (S.A.E.) | 21.38B |
Alexandria Container&Cargo Handling Company | 7.98B |
Egypt Aluminum | 40.94B |